Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arginine-fifty homeobox (ARGFX)
- Target
- ARGFX
- Molecular classification
- Transcription factor, Homeobox gene family
01
Overview
Arginine-fifty homeobox (ARGFX) is a DNA-binding transcription factor belonging to the homeobox gene family, characterized by a conserved homeodomain of 60–63 amino acids. Homeobox genes are typically involved in early embryonic development, and ARGFX is thought to act as a transcriptional activator. Although highly conserved, ARGFX is unique to humans among investigated mammals, originating by gene duplication in early eutherian evolution; its coding sequence is mostly disrupted in other mammals. The gene is primarily expressed in human testis but does not appear to be broadly implicated as a disease-related gene or therapeutic target, nor are any drug interactions or clinical biomarker utilities currently established.
- Other names
- Arginine-fifty homeoboxARGFX
02
Mechanism of action
not applicable, as there are no drugs targeting this transcription factor.
03
Biological functions
Sequence-specific DNA bindingTranscriptional activationEarly embryonic development
04
Disease associations
ARGFX does not have established or well-known disease associations based on current knowledge. Studies suggest possible links through genetic association datasets, but no major direct disease roles are confirmed.
Beyond the preview
Go deeper on Arginine-fifty homeobox (ARGFX).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arginine-fifty homeobox (ARGFX).